Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of pancreatic carcinoma.

× No keyword cloud information.

12 in total

1. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.

Authors: D C Stolinsky; R P Pugh; J R Bateman
Journal: Cancer Chemother Rep Date: 1975 Sep-Oct

Review 2. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.

Authors: S K Carter; R L Comis
Journal: Cancer Treat Rev Date: 1975-09 Impact factor: 12.111

3. Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report.

Authors: P S Schein; P T Lavin; C G Moertel; S Frytak; R G Hahn; M J O'Connell; R J Reitemeier; J Rubin; A J Schutt; L H Weiland; M Kalser; J Barkin; H Lessner; R Mann-Kaplan; D Redlhammer; M Silverman; M Troner; H O Douglass; S Milliron; J Lokich; J Brooks; J Chaffe; A Like; N Zamcheck; K Ramming; J Bateman; H Spiro; E Livstone; A Knowlton
Journal: Cancer Date: 1978-07 Impact factor: 6.860

4. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

Authors: C G Moertel; D S Childs; R J Reitemeier; M Y Colby; M A Holbrook
Journal: Lancet Date: 1969-10-25 Impact factor: 79.321

5. Streptozotocin therapy in 22 cancer patients.

Authors: R W DuPriest; M C Huntington; W H Massey; A J Weiss; W L Wilson; W S Fletcher
Journal: Cancer Date: 1975-02 Impact factor: 6.860

6. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.

Authors: H O Douglass; P T Lavin; C G Moertel
Journal: Cancer Treat Rep Date: 1976-06

7. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.

Authors: R M Bukowski; R T Abderhalden; J S Hewlett; J K Weick; C W Groppe
Journal: Cancer Clin Trials Date: 1980

8. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.

Authors: R G Wiggans; P V Woolley; J S Macdonald; T Smythe; W Ueno; P S Schein
Journal: Cancer Date: 1978-02 Impact factor: 6.860

9. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.

Authors: F P Smith; D F Hoth; B Levin; D A Karlin; J S MacDonald; P V Woolley; P S Schein
Journal: Cancer Date: 1980-11-01 Impact factor: 6.860

10. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.

Authors: J J Lokich; A T Skarin
Journal: Cancer Chemother Rep Date: 1972-10

1 in total

1. Pancreatic cancer: the greatest oncological challenge.

Authors: R C Williamson
Journal: Br Med J (Clin Res Ed) Date: 1988-02-13

1 in total